Buying §48E Credits When You Already Claim the R&D Credit: How §38 Ordering Works

Technology, software and life-science companies often already earn the research credit under §41. When the same C corporation buys §48E clean electricity investment credits under §6418, both credits share one general business credit limit, and the Code decides which one is used first. This page explains that ordering, what it means for sizing a purchase, and what to give your tax team before you sign.

Both credits sit inside one limit

A credit bought under §6418 is treated as the buyer's own credit: the transferee "is treated as the taxpayer for purposes of this title with respect to such credit" (§6418(a)). A purchased §48E credit is part of the investment credit under §46, which lists the clean electricity investment credit as its seventh component (§46(7)). The research credit is a separate component of the general business credit (§38(b)(4)). Both are general business credits, so both are capped by the same §38(c) limit; see our §38(c) guide. For a C corporation with no tentative minimum tax, that cap is roughly 75% of net regular tax plus $6,250.

Which credit is used first

Three rules decide the order:

1. Carryforwards before current-year credits. The Form 3800 instructions say general business credits are used first-in, first-out: carryforwards to the year (earliest first), then credits earned in the year, then carrybacks. Credits carried forward are applied before current-year credits.
2. Within a year, the §38(b) list order. §38(d)(1) says credits are used in the order they are listed in §38(b). The investment credit is listed first (§38(b)(1)); the research credit is fourth (§38(b)(4)). Within the investment credit, §38(d)(2) uses the order in §46, and the Form 3800 instructions list the clean electricity investment credit last among the investment credit components.
3. Specified credits are computed separately. The research credit of an "eligible small business" (generally a non-public company with average gross receipts of $50 million or less, §38(c)(5)) is a "specified credit" under §38(c)(4)(B)(ii). Specified credits get their own limit, which is reduced by the other general business credits allowed for the year (§38(c)(4)(A)). §48E is not on the specified-credit list in the text we reviewed.

The practical result: in the year of purchase, a current-year §48E credit is generally applied before the company's current-year research credit, whether or not the research credit is a specified credit. Older carryforwards, including research credit carryforwards, are applied before both.

What that means for sizing a purchase

The total credit you can use in a year does not change because of ordering. What changes is which credit is left over. If you buy more §48E credit than the room left after your own credits, the excess does not sit on the §48E side; it pushes your own research credit into a carryforward. You paid cash for credit used this year while a credit you earned for free is deferred.

Illustration (hypothetical, TMT assumed zero, not a CAMT company)	Amount
Net regular tax	$1,000,000
§38(c) cap: $1,000,000 − 25% × ($1,000,000 − $25,000)	$756,250
Current-year research credit (no carryforwards)	$300,000
Room left for a purchased credit ($756,250 − $300,000)	$456,250
If the company buys $600,000 of §48E: §48E used first	$600,000 used
Research credit used with the $156,250 of room left	$156,250 used
Research credit carried over (1 year back, 20 forward under §39(a)(1))	$143,750

Buying $456,250 instead would have used every dollar of both credits this year. These are illustrative numbers, not a projection or a promise of savings.

Carryover rules differ by credit

• Research credit: the general rule, carried back 1 year and forward 20 years (§39(a)(1)).
• §48E and other "applicable credits" (§6417(b)): §39 is applied separately from other business credits, with a 3-year carryback and a 20-year carryforward (§39(a)(4); the Form 3800 instructions state "carried back 3 years and carried forward 20 years").
• Carryforwards still meet the §38(c) cap each later year, and the cash paid for a purchased credit earns less when the benefit arrives later. See carryforward and carryback rules.

Other things that shrink the room

• §174A expensing and bonus depreciation. Deducting domestic research costs immediately lowers taxable income and therefore the §38(c) cap. Model capacity after those deductions; see credit capacity after bonus depreciation and §174A.
• Payroll tax election. A qualified small business may elect under §41(h) to apply part of its research credit against payroll taxes (Form 6765). That portion does not use income tax room, and the Form 3800 instructions require the research credit carryforward to be reduced by the amount elected.
• CAMT. For an applicable corporation under the 15% corporate alternative minimum tax, the interaction is different; see CAMT and purchased §48E credits.
• Estimated tax. If you plan to count the credit in quarterly payments, see estimated tax payments and credit purchases.

What to give your tax team before you sign

1. A projection of net regular tax for the purchase year after §174A, bonus depreciation and other deductions.
2. Current-year research credit estimate (Form 6765) and any payroll tax election.
3. All general business credit carryforwards by year and type (they are used first).
4. Whether the company is an eligible small business under §38(c)(5) and whether it is an applicable corporation for CAMT.
5. A purchase size that fills the room left, not the gross tax bill, plus a margin if the projection is uncertain.

Then run the diligence on the credit itself: registration number, placed-in-service evidence, §50 recapture allocation and FEOC representations. Start with the §48E diligence checklist and the C corporation buyer guide.

Educational information only, not tax, legal or investment advice, and no outcome is promised. Rules were checked against the cited sources on November 9, 2026; they change, so confirm with your CPA and counsel before acting. Veritas does not offer or solicit investments. See our disclaimer.